{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:47:05Z","timestamp":1776260825136,"version":"3.50.1"},"reference-count":17,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":635,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,3,29]]},"abstract":"<jats:p>This prospective study compared continuous and intermittent chlorambucil therapy of untreated Waldenstr\u00f6m's macroglobulinaemia. The diagnosis was established by the presence of an IgM monoclonal (M\u2010) protein in the serum, an infiltrate of lymphocytes and plasma cells in the bone marrow, anaemia or other laboratory abnormalities, physical findings or constitutional symptoms. Patients were randomized to receive chlorambucil 0.1\u2003mg\/kg\/d or chlorambucil 0.3\u2003mg\/kg\/d orally for 7\u2003d, repeated every 6 weeks. Criteria for response included 50% or more reduction of serum M\u2010protein, increase in haemoglobin level of 2\u2003g\/dl without transfusion, \u2265\u200350% decrease of urine M\u2010protein, or a reduction of 2\u2003cm in the size of the liver, spleen or lymph nodes. Forty\u2010six patients were randomized to continuous chlorambucil (<jats:italic>n<\/jats:italic>\u2003=\u200324) or to intermittent chlorambucil (<jats:italic>n<\/jats:italic>\u2003=\u200322). Nineteen (79%) (95% CI\u2003=\u200358\u201393) of the 24 patients given continuous therapy had an objective improvement by either reduction of serum M\u2010protein or increase in haemoglobin. Fifteen (68%) (95% CI\u2003=\u200345\u201386) of the 22 patients given chlorambucil intermittently had an objective response. The size of the liver decreased by \u2265\u20032\u2003cm in 55% of patients, and the size of the spleen decreased \u2265\u20032\u2003cm in 67%. Lymphadenopathy decreased in 71%. Acute leukaemia or refractory anaemia developed in four patients. The median duration of survival was 5.4 years, and there was no difference between the regimens. Chlorambucil is effective for the treatment of Waldenstr\u00f6m's macroglobulinaemia. Patients must be treated for at least 6 months before therapy is abandoned because response is slow. Chlorambucil is an effective agent and should be compared with purine analogues or rituxan (Rituximab) in a prospective study.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.01918.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:23:03Z","timestamp":1047363783000},"page":"737-742","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["Waldenstr\u00f6m's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil"],"prefix":"10.1111","volume":"108","author":[{"given":"Robert A.","family":"Kyle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip R.","family":"Greipp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morie A.","family":"Gertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Witzig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Lust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha Q.","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry M.","family":"Therneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"135","article-title":"Continuous chlorambucil therapy in primary macroglobulinemia of Waldenstr\u00f6m: report of four cases","volume":"36","author":"Bayrd E.D.","year":"1961","journal-title":"Proceedings of the Staff Meetings of the Mayo Clinic"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1964.03070100023004"},{"key":"e_1_2_6_4_1","first-page":"106a","article-title":"Rituximab therapy in previously treated Waldenstrom's macroglobulinemia: preliminary evidence of activity (Abstract)","volume":"92","author":"Byrd J.C.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.3109\/07357909109032794"},{"key":"e_1_2_6_6_1","first-page":"317","article-title":"2\u2010Chlorodeoxyadenosine therapy in Waldenstr\u00f6m's macroglobulinaemia","volume":"36","author":"Delannoy A.","year":"1994","journal-title":"Nouvelle Revue Fran\u00e7aise d'H\u00e9matologie"},{"key":"e_1_2_6_7_1","first-page":"577a","article-title":"Phase II intergroup trial of fludarabine (FAMP) in Waldenstr\u00f6m's macroglobulinemia (WM): results of Southwest Oncology Group trial (SWOG 9003) in 220 patients (Abstract)","volume":"90","author":"Dhodapkar M.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood.V83.6.1452.1452","article-title":"Waldenstr\u00f6m's macroglobulinemia","volume":"83","author":"Dimopoulos M.A.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058811"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1200\/JCO.1994.12.12.2694","article-title":"Primary therapy of Waldenstr\u00f6m's macroglobulinemia with paclitaxel (Letter)","volume":"12","author":"Dimopoulos M.A.","year":"1994","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a059040"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01493.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.2.546"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1361.1361"},{"key":"e_1_2_6_15_1","unstructured":"Jaffe E.S.(1998) Histopathology of the non\u2010Hodgkin's lymphomas and Hodgkin's disease.The Lymphomas(ed. by G.P. Canellos T.A. Lister & J.L. Sklar) pp.77106. W.B. Saunders Philadelphia."},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.6.2060"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.01069.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1989.tb01422.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01918.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01918.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.01918.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T07:03:12Z","timestamp":1698562992000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.01918.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3,29]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,3,29]]}},"alternative-id":["10.1046\/j.1365-2141.2000.01918.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.01918.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3,29]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}